Other News To Note
Wednesday, December 7, 2011
Numerate Inc., of San Bruno, Calif., entered a research collaboration with Boehringer Ingelheim (Canada) Ltd., of Burlington, Ontario. The collaboration will use Numerate's in silico drug design technology to generate small-molecule drug leads for an undisclosed infectious disease target.
Outside of the US
Part of Thomson Reuters
Note: our contact information has changed
In the U.S. and Canada: +1-800-336-4474
Outside the U.S.: +44-203-684-1796
Hours: Monday - Friday, 8:00am - 6:00 pm EST
© 2017 Thomson Reuters. Reproduction, reposting content is strictly prohibited.